Artificial Intelligence Systems for Diabetic Retinopathy Screening: Appraisal on the 3rd US FDA Approved Algorithms- AEYE-DS
Journal Title: Journal of Ophthalmology and Advance Research - Year 2023, Vol 4, Issue 2
Abstract
Artificial Intelligence (AI) has revolutionized the field of healthcare in recent years, and one of its most promising applications is on the interpretation of medical images [1]. In ophthalmology, the first success comes to the screening and diagnosis of Diabetic Retinopathy (DR) [2]. DR is a common complication of Diabetes Mellitus (DM) that affects the eyes, and early detection and treatment is crucial in preventing vision loss, especially over the working populations [3]. The use of AI in DR screening involves analyzing digital fundus images to detect any signs of DR, including microaneurysms, dot and blot haemorrhages, cotton-wool spots, venous beading, intraretinal microvascular anomalies [4]. Currently, there are 3 US FDA approved systems on DR screening, IDx-DR (Digital Diagnostics), EyeArt (Eyenuk, Inc) and AEYE-DS (AEYE Health, Inc) [5-7]. AI has several advantages over traditional screening methods, including usage by non-ophthalmologically trained medical personnel, accessible and stable performance over whatever time and place, increased speed of clinical workflow, these might potentially help to improve outcomes for patients with DM. In the era of rapidly advancing technology, the use of AI in ophthalmology is an exciting development that might transform our future practice [8]. In this appraisal, we focus on the 3rd US FDA approved AI algorithms for DR.
Authors and Affiliations
Vanessa, Ching Chi Lee, Sunny Chi Lik Au
Myopia and Environmental Risk Factors: A Comprehensive Study
Background: The global rise in the prevalence of myopia calls for evidence-based strategies to be devised to reduce the incidence and delay the progression of Myopia. The aim is to determine the relationship between myop...
Mercureid Gives New Opportunities for Treatment and Prevention of Complications Caused by COVID-19 in Patients with Ophthalmic Pathologies
The coming era of COVID-19 introduces critical challenges for researchers. Accordingly, new questions connected with the current state of people’s health arise, namely, what consequences will be for the patients who ha...
Pattern of increase in Spherical Aberration and Coma After Femtosecond Laser Assisted In-Situ Keratomileusis Using an Aspheric Ablation Profile
Purpose: To determine the contribution of spherical aberration and coma to the total ocular high order aberration before and after femto laser-assisted in-situ keratomileusis using an aspheric ablation profile. Method...
Patients’ Awareness and Knowledge of Their Ophthalmic Condition at Lagos University Teaching Hospital (LUTH)
Purpose: To assess patient’s awareness of their ophthalmic conditions following their clinic visits with the aim of improving communication between patients and health practitioners and enhancing care. Methods: A hosp...
Optical Coherence Tomography Angiography for Macular Telangiectasia Type 2
Optical Coherence Tomography Angiography (OCT-A) is an evolving retinal imaging modality for vascular diseases. By avoiding the intravenous fluorescein dye and its associated complications, OCT-A better identifies abnorm...